Cargando…
p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer
Adaptation of the lipid metabolism participates in cancer pathogenesis, facilitating energy storage and influencing cell fate and control of molecular signalling. The tumour suppressor protein p53 is a molecular hub of cell metabolism, supporting antioxidant capabilities and counteracting oncogene-...
Autores principales: | Butera, Alessio, Roy, Micaela, Zampieri, Carlotta, Mammarella, Eleonora, Panatta, Emanuele, Melino, Gerry, D’Alessandro, Angelo, Amelio, Ivano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902766/ https://www.ncbi.nlm.nih.gov/pubmed/35255936 http://dx.doi.org/10.1186/s13062-022-00319-9 |
Ejemplares similares
-
NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
por: Mammarella, Eleonora, et al.
Publicado: (2021) -
Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021) -
p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer
por: Zampieri, Carlotta, et al.
Publicado: (2022) -
p53 regulates expression of nuclear envelope components in cancer cells
por: Panatta, Emanuele, et al.
Publicado: (2022) -
Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)